Monitoring quality control of nuchal translucency

Clinics in Laboratory Medicine

Volumn 30, Issue 3, 2010, Pages 593-604

  Cuckle, Howard ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

Down syndrome; Nuchal; Prenatal; Quality; Screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOWN SYNDROME; FETUS ECHOGRAPHY; HUMAN; IMAGE QUALITY; MATHEMATICAL MODEL; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; QUALITY CONTROL; REVIEW; BIOLOGICAL MODEL; FEMALE; MASS SCREENING; PREDICTIVE VALUE; PREGNANCY; PROCEDURES; STANDARDS;

BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MODELS, BIOLOGICAL; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY;

EID: 77954774155     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.04.012     Document Type: Review

References (26)

1. Cuckle H., Benn P. Multianalyte maternal serum screening for chromosomal defects. Genetic disorders and the fetus: diagnosis, prevention and treatment 2009, 771-818. Johns Hopkins University Press, Baltimore (MD). 6th edition. A. Milunsky (Ed.).
2. Spencer K., Bindra R., Nix A.B., et al. Delta-NT or NT MoM, which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?. Ultrasound Obstet Gynecol 2003, 22:142-148.
3. Wright D., Kagan K.O., Molina F.S., et al. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008, 31(4):376-383.
4. Wald N.J., Rodeck C., Hackshaw A.K., et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003, 7(11):1-88.
5. Malone F.D., Canick J.A., Ball R.H., First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium, et al. First trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353(19):2001-2011.
6. Wright D., Bradbury I., Benn P., et al. Contingent screening for Down's syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 2004, 24(10):762-766.
7. Cuckle H., Aitken D., Goodburn S., UK National Down's Syndrome Screening Programme, Laboratory Advisory Group, et al. Age-standardisation when target setting and auditing performance of Down syndrome screening programmes. Prenat Diagn 2004, 24(11):851-856.
8. Canick J.A., Lambert-Messerlian G.M., Palomaki G.E., First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium, et al. Comparison of serum markers in first-trimester Down syndrome screening. Obstet Gynecol 2006, 108:1192-1199.
9. Cuckle H.S., Malone F.D., Wright D., FaSTER Research Consortium, et al. Contingent screening for Down syndrome-results from the FaSTER trial. Prenat Diagn 2008, 28:89-94.
10. Weisz B., Pandya P.P., David A.L., et al. Ultrasound findings after screening for Down syndrome using the integrated test. Obstet Gynecol 2007, 109:1046-1052.
11. Okun N., Summers A., Hoffman B., et al. Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center. Prenat Diagn 2008, 8:987-992.
12. Wald N.J., Huttly W.J., Murphy K.W., et al. Antenatal screening for Down's syndrome using the Integrated test at two London hospitals. J Med Screen 2009, 16(1):7-10.
13. Rodrigues L.C., Ramos-Dias A.M., Carvalho V., et al. Evaluation of four years of prenatal screening for aneuploidies in Hospital S. Francisco Xavier using the integrated test. J Med Screen 2009, 16(1):46-47.
14. Benn P.A., Campbell W.A., Zelop C.M., et al. Stepwise sequential screening for fetal aneuploidy. Am J Obstet Gynecol 2007, 197(3):312. e1-5.
15. Snijders R.J., Thom E.A., Zachary J.M., et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002, 19(4):353-359.
16. Herman A., Maymon R., Dreazen E., et al. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol 1998, 12:398-403.
17. Wøjdemann K.R., Christiansen M., Sundberg K., et al. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol 2001, 18(6):641-644.
18. Fries N., Althuser M., Fontanges M., et al. Quality control of an image-scoring method for nuchal translucency ultrasonography. Am J Obstet Gynecol 2007, 196(3):272. e1-5.
19. Logghe H., Cuckle H., Sehmi I. Centre-specific ultrasound nuchal translucency medians needed for Down's syndrome screening. Prenat Diagn 1995, 23(5):389-392.
20. Frey Tirri B., Troeger C., Holzgreve W., et al. Quality management of nuchal translucency measurement in residents. Ultraschall Med 2007, 28(5):484-488.
21. Evans M.I., Van Decruyes H., Nicolaides K.H. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007, 22:401-404.
22. Gyselaers W.J., Vereecken A.J., Van Herck E.J., et al. Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization. Ultrasound Obstet Gynecol 2004, 24(5):511-515.
23. Palomaki G.E., Neveux L.M., Donnenfeld A., et al. Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med 2008, 10(2):131-138.
24. D'Alton M.E., Cleary-Goldman J., Lambert-Messerlian G., et al. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial. Ultrasound Obstet Gynecol 2009, 33(2):142-146.
25. Koster M.P., Wortelboer E.J., Engels M.A., et al. Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis. Ultrasound Obstet Gynecol 2009, 34(2):136-141.
26. Nicolaides K.H., Snijders R.J., Cuckle H.S. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1998, 18(5):519-523.